Biomeme, INC.

Company has developed a rapid pcr test for covid-19 and an array of chem-bio threats

Based in PA

🤖

AI Overview

With $410K in lobbying spend across 14 quarterly filings, Biomeme, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2022 to 2025.

$410K
Total Spend
4
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$140K
2023$240K
2024$30K
2025$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, MED, Health Issues

  • FY23 Defense Authorization and Appropriations Acts; FY23 Labor-HHS-Education Appropriations Acts
  • Advocacy to House and Senate to support Defense Authorization and Defense Appropriations efforts related funding from the Department of Defense to develop and deploy handheld devices to detect and ide
  • Advocacy to House and Senate to support Appropriations efforts related funding from the Department of Health and Human Services to develop and deploy handheld devices to detect and identify chemical,
  • Promoting policies and funding streams within the Defense Appropriations Subcommittee to bolster chemical and biological weapons detection capabilities

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.